Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DOPAMINE D1 RECEPTOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 119 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ni, ZG; Bouali-Benazzouz, R; Gao, DM; Benabid, AL; Benazzouz, A
      Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat

      SYNAPSE
    2. Adams, DH; Hanson, GR; Keefe, KA
      Differential effects of cocaine and methamphetamine on neurotensin/neuromedin N and preprotachykinin messenger RNA expression in unique regions of the striatum

      NEUROSCIENCE
    3. Chapman, DE; Hanson, GR; Kesner, RP; Keefe, KA
      Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    4. Martin, MW; Scott, AW; Johnston, DE; Griffin, S; Luedtke, RR
      Typical antipsychotics exhibit inverse agonist activity at rat dopamine D1-like receptors expressed in Sf9 cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    5. Millan, MJ; Newman-Tancredi, A; Quentric, Y; Cussac, D
      The '' selective '' dopamine D-1 receptor antagonist, SCH23390, is a potent and high efficacy agonist at cloned human serotonin(2C) receptors

      PSYCHOPHARMACOLOGY
    6. Worsley, JN; Moszczynska, A; Falardeau, P; Kalasinsky, KS; Schmunk, G; Guttman, M; Furukawa, Y; Ang, L; Adams, V; Reiber, G; Anthony, RA; Wickham, D; Kish, SJ
      Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users

      MOLECULAR PSYCHIATRY
    7. Sautel, M; Milligan, G
      Molecular manipulation of G-protein-coupled receptors: A new avenue into drug discovery

      CURRENT MEDICINAL CHEMISTRY
    8. Yung, KKL; Bolam, JP
      Localization of dopamine D1 and D2 receptors in the rat neostriatum: Synaptic interaction with glutamate- and GABA-containing axonal terminals

      SYNAPSE
    9. Johnson, PI; Napier, TC
      Ventral pallidal injections of a mu antagonist block the development of behavioral sensitization to systemic morphine

      SYNAPSE
    10. Mehta, A; Thermos, K; Chesselet, MF
      Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions

      SYNAPSE
    11. van de Witte, SV; Groenewegen, HJ; Drukarch, B; Voorn, P
      Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats

      NEUROSCIENCE LETTERS
    12. Paul, S; Snyder, GL; Yokakura, H; Picciotto, MR; Nairn, AC; Lombroso, PJ
      The dopamine/D1 receptor mediates the phosphorylation and inactivation of the protein tyrosine phosphatase STEP via a PKA-dependent pathway

      JOURNAL OF NEUROSCIENCE
    13. Leff, P; Morales, A; Calva, JC; Medecigo, M; Acevedo, R; Valdez, A; Lima, C; Anton, B
      Neurobiology of addiction: neuroanatomical, neurochemical, molecular and genetic aspects of morphine and cocaine addiction. Part III

      SALUD MENTAL
    14. Czyrak, A; Chocyk, A; Mackowiak, M; Fijal, K; Wedzony, K
      Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study

      MOLECULAR BRAIN RESEARCH
    15. Radulovic, J; Blank, T; Nijholt, I; Kammermeier, J; Spiess, J
      In vivo NMDA/dopamine interaction resulting in Fos production in the limbic system and basal ganglia of the mouse brain

      MOLECULAR BRAIN RESEARCH
    16. Adams, DH; Hanson, GR; Keefe, KA
      Cocaine and methamphetamine differentially affect opioid peptide mRNA expression in the striatum

      JOURNAL OF NEUROCHEMISTRY
    17. Noda, Y; Nabeshima, T
      Role of catecholaminergic and cyclic AMP systems in psychological dependence on phencyclidine: A study in mutant mice

      JAPANESE JOURNAL OF PHARMACOLOGY
    18. Ekesbo, A; Andren, PE; Gunne, LM; Sonesson, C; Tedroff, J
      Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopaminelesions

      EUROPEAN JOURNAL OF PHARMACOLOGY
    19. Abekawa, T; Ohmori, T; Ito, K; Koyama, T
      D1 dopamine receptor activation reduces extracellular glutamate and GABA concentrations in the medial prefrontal cortex

      BRAIN RESEARCH
    20. McGrath, MJ; Campbell, KM; Veldman, MB; Burton, FH
      Anxiety in a transgenic mouse model of cortical-limbic neuropotentiated compulsive behavior

      BEHAVIOURAL PHARMACOLOGY
    21. Mayes, LC
      Developing brain and in utero cocaine exposure: Effects on neural ontogeny

      DEVELOPMENT AND PSYCHOPATHOLOGY
    22. Neal-Beliveau, BS; Joyce, JN
      Timing: A critical determinant of the functional consequences of neonatal 6-OHDA lesions

      NEUROTOXICOLOGY AND TERATOLOGY
    23. Vanderschuren, LJMJ; Wardeh, G; De Vries, TJ; Mulder, AH; Schoffelmeer, ANM
      Opposing role of dopamine D1 and D2 receptors in modulation of rat nucleusaccumbens noradrenaline release

      JOURNAL OF NEUROSCIENCE
    24. Kojima, H; Ohmori, O; Shinkai, T; Terao, T; Suzuki, T; Abe, H
      Dopamine D1 receptor gene polymorphism and schizophrenia in Japan

      AMERICAN JOURNAL OF MEDICAL GENETICS
    25. O'Neill, MF; Heron-Maxwell, CL; Shaw, G
      5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D-1 agonist C-APB

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    26. Geurts, M; Hermans, E; Maloteaux, JM
      Assessment of striatal D1 and D2 dopamine receptor-G protein coupling by agonist-induced [S-35]GTP gamma S binding

      LIFE SCIENCES
    27. Nishi, A; Fisone, G; Snyder, GL; Dulubova, I; Aperia, A; Nairn, AC; Greengard, P
      Regulation of Na+,K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C

      JOURNAL OF NEUROCHEMISTRY
    28. Bloch, B; Dumartin, B; Bernard, V
      In vivo regulation of intraneuronal trafficking of G protein-coupled receptors for neurotransmitters

      TRENDS IN PHARMACOLOGICAL SCIENCES
    29. DZIEWCZAPOLSKI G; MENALLED LB; GARCIA MC; MORA MA; GERSHANIK OS; RUBINSTEIN M
      OPPOSITE ROLES OF D1 AND D5 DOPAMINE-RECEPTORS IN LOCOMOTION REVEALEDBY SELECTIVE ANTISENSE OLIGONUCLEOTIDES

      NeuroReport
    30. COLTHORPE KL; ANDERSON ST; MARTIN GB; CURLEWIS JD
      HYPOTHALAMIC DOPAMINE D1 RECEPTORS ARE INVOLVED IN THE STIMULATION OFPROLACTIN SECRETION BY HIGH ENVIRONMENTAL-TEMPERATURE IN THE FEMALE SHEEP

      Journal of neuroendocrinology
    31. HARLAN RE; GARCIA MM
      DRUGS OF ABUSE AND IMMEDIATE-EARLY GENES IN THE FOREBRAIN

      Molecular neurobiology
    32. Reiner, A; Perera, M; Paullus, R; Medina, L
      Immunohistochemical localization of DARPP32 in striatal projection neuronsand striatal interneurons in pigeons

      JOURNAL OF CHEMICAL NEUROANATOMY
    33. NISENBAUM ES; MERMELSTEIN PG; WILSON CJ; SURMEIER DJ
      SELECTIVE BLOCKADE OF A SLOWLY INACTIVATING POTASSIUM CURRENT IN STRIATAL NEURONS BY (+ -)6-CHLORO-APB HYDROBROMIDE (SKF82958)/

      Synapse
    34. RAJADHYAKSHA A; LEVEQUE JC; MACIAS W; BARCZAK A; KONRADI C
      MOLECULAR-COMPONENTS OF STRIATAL PLASTICITY - THE VARIOUS ROUTES OF CYCLIC-AMP PATHWAYS

      Developmental neuroscience
    35. CRABBE JC; PHILLIPS TJ
      GENETICS OF ALCOHOL AND OTHER ABUSED DRUGS

      Drug and alcohol dependence
    36. LU XY; GHASEMZADEH MB; KALIVAS PW
      EXPRESSION OF D-1 RECEPTOR, D-2 RECEPTOR, SUBSTANCE-P AND ENKEPHALIN MESSENGER-RNAS IN THE NEURONS PROJECTING FROM THE NUCLEUS-ACCUMBENS

      Neuroscience
    37. DRAGO J; PADUNGCHAICHOT P; WONG JYF; LAWRENCE AJ; MCMANUS JF; SUMARSONO SH; NATOLI AL; LAKSO M; WREFORD N; WESTPHAL H; KOLA I; FINKELSTEIN DI
      TARGETED EXPRESSION OF A TOXIN GENE TO D1 DOPAMINE-RECEPTOR NEURONS BY CRE-MEDIATED SITE-SPECIFIC RECOMBINATION

      The Journal of neuroscience
    38. ARNAULD E; ARSAUT J; DEMOTESMAINARD J
      CONDITIONAL COUPLING OF STRIATAL DOPAMINE D1 RECEPTOR TO TRANSCRIPTION FACTORS - ONTOGENIC AND REGIONAL DIFFERENCES IN CREB ACTIVATION

      Molecular brain research
    39. SASAKI T; KENNEDY JL; NOBREGA JN
      REGIONAL BRAIN CHANGES IN [H-3]SCH-23390 BINDING TO DOPAMINE D1, RECEPTORS AFTER LONG-TERM HALOPERIDOL TREATMENT - LACK OF CORRESPONDENCE WITH THE DEVELOPMENT OF VACUOUS CHEWING MOVEMENTS

      Behavioural brain research
    40. SVENNINGSSON P; LEMOINE C; AUBERT I; BURBAUD P; FREDHOLM BB; BLOCH B
      CELLULAR-DISTRIBUTION OF ADENOSINE A(2A) RECEPTOR MESSENGER-RNA IN THE PRIMATE STRIATUM

      Journal of comparative neurology
    41. STEINER H; GERFEN CR
      ROLE OF DYNORPHIN AND ENKEPHALIN IN THE REGULATION OF STRIATAL OUTPUTPATHWAYS AND BEHAVIOR

      Experimental Brain Research
    42. BONI R; LICHTENSTEIGER W; STEINERT HC; BONI RAH; FRUH H; DUMMER R; HARTMANN DG; LAINE E; BURG G
      D1 DOPAMINE-RECEPTORS ARE NOT EXPRESSED IN HUMAN-MELANOMA

      Melanoma research
    43. CHERGUI K; SVENNINGSSON P; NOMIKOS GG; GONON F; FREDHOLM BB; SVENNSON TH
      INCREASED EXPRESSION OF NGFI-A MESSENGER-RNA IN THE RAT STRIATUM FOLLOWING BURST STIMULATION OF THE MEDIAL FOREBRAIN-BUNDLE

      European journal of neuroscience
    44. HU XT; WHITE FJ
      DOPAMINE ENHANCES GLUTAMATE-INDUCED EXCITATION OF RAT STRIATAL NEURONS BY COOPERATIVE ACTIVATION OF D1 AND D2 CLASS RECEPTORS

      Neuroscience letters
    45. OBRIETAN K; VANDENPOL AN
      GABA ACTIVITY MEDIATING CYTOSOLIC CA2-DEPENDENT SIGNAL-TRANSDUCTION( RISES IN DEVELOPING NEURONS IS MODULATED BY CAMP)

      The Journal of neuroscience
    46. STEELE TD; HODGES DB; LEVESQUE TR; LOCKE KW
      D-1 AGONIST DIHYDREXIDINE RELEASES ACETYLCHOLINE AND IMPROVES COGNITIVE PERFORMANCE IN RATS

      Pharmacology, biochemistry and behavior
    47. DEVENEY AM; WADDINGTON JL
      PSYCHOPHARMACOLOGICAL DISTINCTION BETWEEN NOVEL FULL-EFFICACY D-1-LIKE DOPAMINE-RECEPTOR AGONISTS

      Pharmacology, biochemistry and behavior
    48. SOUBROUILLARD C; LOMBARDO C; RASCOL O; BRUGUEROLLE B; BLIN O
      CENTRAL DOPAMINERGIC D1 AGONISTS IN THE T REATMENT OF PARKINSONS-DISEASE

      Therapie
    49. STOESSL AJ; JAMES KA; NAPIER BJ
      THE NEUROTENSIN ANTAGONIST SR-48692 FAILS TO MODIFY THE BEHAVIORAL-RESPONSES TO A DOPAMINE D1 RECEPTOR AGONIST IN THE RAT

      Neuropharmacology
    50. BERNABEU R; BEVILAQUA L; ARDENGHI P; BROMBERG E; SCHMITZ P; BIANCHIN M; IZQUIERDO I; MEDINA JH
      INVOLVEMENT OF HIPPOCAMPAL CAMP CAMP-DEPENDENT PROTEIN-KINASE SIGNALING PATHWAYS IN A LATE MEMORY CONSOLIDATION PHASE OF AVERSIVELY MOTIVATED LEARNING IN RATS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    51. PACHECO MA; JOPE RS
      COMPARISON OF [H-3] PHOSPHATIDYLINOSITOL AND [H-3] PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE HYDROLYSIS IN POSTMORTEM HUMAN BRAIN MEMBRANES ANDCHARACTERIZATION OF STIMULATION BY DOPAMINE D1 RECEPTORS

      Journal of neurochemistry
    52. COUSINS MS; CARRIERO DL; SALAMONE JD
      TREMULOUS JAW MOVEMENTS INDUCED BY THE ACETYLCHOLINESTERASE INHIBITORTACRINE - EFFECTS OF ANTIPARKINSONIAN DRUGS

      European journal of pharmacology
    53. WIRTSHAFTER D; SCHARDT G; ASIN KE
      COMPARTMENTALLY SPECIFIC EFFECTS OF QUINPIROLE ON THE STRIATAL FOS EXPRESSION INDUCED BY STIMULATION OF D-1-DOPAMINE RECEPTORS IN INTACT RATS

      Brain research
    54. SMITH TS; TRIMMER PA; KHAN SM; TINKLEPAUGH DL; BENNETT JP
      MITOCHONDRIAL TOXINS IN MODELS OF NEURODEGENERATIVE DISEASES .2. ELEVATED ZIF268 TRANSCRIPTION AND INDEPENDENT TEMPORAL REGULATION OF STRIATAL D1 AND D2 RECEPTOR MESSENGER-RNAS AND D1 AND D2 RECEPTOR-BINDING SITES IN C57BL 6 MICE DURING MPTP TREATMENT/

      Brain research
    55. WAN FJ; TAAID N; SWERDLOW NR
      DO D-1 D-2 INTERACTIONS REGULATE PREPULSE INHIBITION IN RATS/

      Neuropsychopharmacology
    56. VARGO JM; MARSHALL JF
      FRONTAL-CORTEX ABLATION REVERSIBLY DECREASES STRIATAL ZIF 268 AND JUNB EXPRESSION - TEMPORAL CORRESPONDENCE WITH SENSORY NEGLECT AND ITS SPONTANEOUS-RECOVERY/

      Synapse
    57. WANG JQ; MCGINTY JF
      D-1 AND D-2 RECEPTOR REGULATION OF PREPROENKEPHALIN AND PREPRODYNORPHIN MESSENGER-RNA IN RAT STRIATUM FOLLOWING ACUTE INJECTION OF AMPHETAMINE OR METHAMPHETAMINE

      Synapse
    58. CURRAN EJ; AKIL H; WATSON SJ
      PSYCHOMOTOR STIMULANT-INDUCED AND OPIATE-INDUCED C-FOS MESSENGER-RNA EXPRESSION PATTERNS IN THE RAT FOREBRAIN - COMPARISONS BETWEEN ACUTE DRUG-TREATMENT AND A DRUG CHALLENGE IN SENSITIZED ANIMALS

      Neurochemical research
    59. CHERGUI K; NOMIKOS GG; MATHE JM; GONON F; SVENSSON TH
      BURST STIMULATION OF THE MEDIAL FOREBRAIN-BUNDLE SELECTIVELY INCREASES FOS-LIKE IMMUNOREACTIVITY IN THE LIMBIC FOREBRAIN OF THE RAT

      Neuroscience
    60. LATINI S; PAZZAGLI M; PEPEU G; PEDATA F
      A(2) ADENOSINE RECEPTORS - THEIR PRESENCE AND NEUROMODULATORY ROLE INTHE CENTRAL-NERVOUS-SYSTEM

      General pharmacology
    61. LAPRADE N; RADJA F; READER TA; SOGHOMONIAN JJ
      DOPAMINE-RECEPTOR AGONISTS REGULATE LEVELS OF THE SEROTONIN 5-HT2A RECEPTOR AND ITS MESSENGER-RNA IN A SUBPOPULATION OF RAT STRIATAL NEURONS

      The Journal of neuroscience
    62. JUNG AB; BENNETT JP
      DEVELOPMENT OF STRIATAL DOPAMINERGIC FUNCTION .3. PRENATAL-DEVELOPMENT AND POSTNATAL-DEVELOPMENT OF STRIATAL AND CORTICAL MESSENGER-RNAS FOR THE NEUROTROPHIN RECEPTORS TRKB(TK+) AND TRKC AND THEIR REGULATION BY SYNAPTIC DOPAMINE

      Developmental brain research
    63. CICHON S; NOTHEN MM; STOBER G; SCHROERS R; ALBUS M; MAIER W; RIETSCHEL M; KORNER J; WEIGELT B; FRANZEK E; WILDENAUER D; FIMMERS R; PROPPING P
      SYSTEMATIC SCREENING FOR MUTATIONS IN THE 5'-REGULATORY REGION OF THEHUMAN DOPAMINE D-1 RECEPTOR (DRD1) GENE IN PATIENTS WITH SCHIZOPHRENIA AND BIPOLAR AFFECTIVE-DISORDER

      American journal of medical genetics
    64. MINER LL; DRAGO J; CHAMBERLAIN PM; DONOVAN D; UHL GR
      RETAINED COCAINE CONDITIONED PLACE PREFERENCE IN D1 RECEPTOR-DEFICIENT MICE

      NeuroReport
    65. GAMBARANA C; GHIGLIERI O; TADDEI I; TAGLIAMONTE A; DEMONTIS MG
      IMIPRAMINE AND FLUOXETINE PREVENT THE STRESS-INDUCED ESCAPE DEFICITS IN RATS THROUGH A DISTINCT MECHANISM OF ACTION

      Behavioural pharmacology
    66. HUME SP; OPACKAJUFFRY J; MYERS R; AHIER RG; ASHWORTH S; BROOKS DJ; LAMMERTSMA AA
      EFFECT OF L-DOPA AND 6-HYDROXYDOPAMINE LESIONING ON [C-11] RACLOPRIDEBINDING IN RAT STRIATUM, QUANTIFIED USING PET

      Synapse
    67. SITGES M; REYES A
      EFFECTS OF VERAPAMIL ON THE RELEASE OF DIFFERENT NEUROTRANSMITTERS

      Journal of neuroscience research
    68. SIMPSON JN; WANG JQ; MCGINTY JF
      REPEATED AMPHETAMINE ADMINISTRATION INDUCES A PROLONGED AUGMENTATION OF PHOSPHORYLATED CYCLASE RESPONSE ELEMENT-BINDING PROTEIN AND FOS-RELATED ANTIGEN IMMUNOREACTIVITY IN RAT STRIATUM

      Neuroscience
    69. LEVIVIER M; GASH DM; PRZEDBORSKI S
      TIME-COURSE OF THE NEUROPROTECTIVE EFFECT OF TRANSPLANTATION ON QUINOLINIC ACID-INDUCED LESIONS OF THE STRIATUM

      Neuroscience
    70. TRUGMAN JM
      D1 D2 ACTIONS OF DOPAMINERGIC DRUGS STUDIED WITH [C-14] 2-DEOXYGLUCOSE AUTORADIOGRAPHY/

      Progress in neuro-psychopharmacology & biological psychiatry
    71. HENRY DJ; WHITE FJ
      THE PERSISTENCE OF BEHAVIORAL SENSITIZATION TO COCAINE PARALLELS ENHANCED INHIBITION OF NUCLEUS-ACCUMBENS NEURONS

      The Journal of neuroscience
    72. LIU FC; TAKAHASHI H; MCKAY RDG; GRAYBIEL AM
      DOPAMINERGIC REGULATION OF TRANSCRIPTION FACTOR EXPRESSION IN ORGANOTYPIC CULTURES OF DEVELOPING STRIATUM

      The Journal of neuroscience
    73. RICHTAND NM; KELSOE JR; SEGAL DS; KUCZENSKI R
      REGIONAL QUANTIFICATION OF D1, D2, AND D3 DOPAMINE-RECEPTOR MESSENGER-RNA IN RAT-BRAIN USING A RIBONUCLEASE PROTECTION ASSAY

      Molecular brain research
    74. HERVE D; ROGARD M; LEVISTRAUSS M
      MOLECULAR ANALYSIS OF THE MULTIPLE GOLF ALPHA-SUBUNIT MESSENGER-RNAS IN THE RAT-BRAIN

      Molecular brain research
    75. CHOI WS; MACHIDA CA; RONNEKLEIV OK
      DISTRIBUTION OF DOPAMINE D1, D2, AND D5 RECEPTOR MESSENGER-RNAS IN THE MONKEY BRAIN - RIBONUCLEASE PROTECTION ASSAY ANALYSIS

      Molecular brain research
    76. ARNAULD E; ARSAUT J; TAFANI JAM; DEMOTESMAINARD J
      DOPAMINERGIC CONTROL OF GENE-TRANSCRIPTION DURING STRIATAL ONTOGENY -C-FOS INDUCTION BY D1 RECEPTOR ACTIVATION IN THE DEVELOPING STRIOSOMES

      Molecular brain research
    77. JOHNSON BJ; BRUNO JP
      DOPAMINERGIC MODULATION OF STRIATAL ACETYLCHOLINE-RELEASE IN RATS DEPLETED OF DOPAMINE AS NEONATES

      Neuropharmacology
    78. HUANG YY; KANDEL ER
      D1 D5 RECEPTOR AGONISTS INDUCE A PROTEIN SYNTHESIS-DEPENDENT LATE POTENTIATION IN THE CA1 REGION OF THE HIPPOCAMPUS/

      Proceedings of the National Academy of Sciences of the United Statesof America
    79. GANCHER S; CRABBE J; GARLAND A; LEA E; WOODWARD W
      DOSE-DEPENDENT AND DURATION-DEPENDENT TOLERANCE TO ROTATIONAL EFFECTSOF APOMORPHINE IN A RAT MODEL OF PARKINSONISM

      The Journal of pharmacology and experimental therapeutics
    80. LIU F; YUAN H; SUGAMORI KS; HAMADANIZADEH A; LEE FJS; PANG SF; BROWN GM; PRISTUPA ZB; NIZNIK HB
      MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF A PARTIAL CDNA-ENCODING A NOVEL CHICKEN BRAIN MELATONIN RECEPTOR

      FEBS letters
    81. BAKOWSKA JC; MORRELL JI
      QUANTITATIVE AUTORADIOGRAPHIC ANALYSIS OF D-1 AND D-2 DOPAMINE-RECEPTORS IN RAT-BRAIN IN EARLY AND LATE PREGNANCY

      Brain research
    82. BOLDRY RC; PAPA SM; KASK AM; CHASE TN
      MK-8O1 REVERSES EFFECTS OF CHRONIC LEVODOPA ON D1 AND D2 DOPAMINE AGONIST-INDUCED ROTATIONAL BEHAVIOR

      Brain research
    83. GNANALINGHAM KK; HUNTER AJ; JENNER P; MARSDEN CD
      STIMULATION OF ADENYLATE-CYCLASE ACTIVITY BY BENZAZEPINE D-1 DOPAMINEAGONISTS WITH VARYING EFFICACIES IN THE 6-HYDROXYDOPAMINE LESIONED RAT-RELATIONSHIP TO CIRCLING BEHAVIOR

      Biochemical pharmacology
    84. GNANALINGHAM KK; EROL DD; HUNTER AJ; SMITH LA; JENNER P; MARSDEN CD
      DIFFERENTIAL ANTI-PARKINSONIAN EFFECTS OF BENZAZEPINE D-1 DOPAMINE AGONISTS WITH VARYING EFFICACIES IN THE MPTP-TREATED COMMON MARMOSET

      Psychopharmacology
    85. RYU JH; YANAI K; IWATA R; IDO T; WATANABE T
      HETEROGENEOUS DISTRIBUTIONS OF HISTAMINE H3, DOPAMINE D1 AND D2 RECEPTORS IN RAT-BRAIN

      NeuroReport
    86. ALNASER HA; COOPER SJ
      A-68930, A NOVEL, POTENT DOPAMINE D1 RECEPTOR AGONIST - A MICROSTRUCTURAL ANALYSIS OF ITS EFFECTS ON FEEDING AND OTHER BEHAVIOR IN THE RAT

      Behavioural pharmacology
    87. TRUGMAN JM; LEADBETTER R; ZALIS ME; BURGDORF RO; WOOTEN GF
      TREATMENT OF SEVERE AXIAL TARDIVE DYSTONIA WITH CLOZAPINE - CASE-REPORT AND HYPOTHESIS

      Movement disorders
    88. KASSIOU M; MATHEWS WB; MUSACHIO JL; RAVERT HT; LAMBRECHT RM; DANNALS RF
      RADIOSYNTHESIS OF (+ OXY-2[C-11]-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE, [C-11] A-69024 - A NON-BENZAZEPINE ANTAGONIST FOR STUDYING DOPAMINED1 RECEPTORS IN-VIVO USING PET/

      Journal of labelled compounds & radiopharmaceuticals
    89. WATSON JB; COULTER PM; MARGULIES JE; DELECEA L; DANIELSON PE; ERLANDER MG; SUTCLIFFE JG
      G-PROTEIN GAMMA-7 SUBUNIT IS SELECTIVELY EXPRESSED IN MEDIUM-SIZED NEURONS AND DENDRITES OF THE RAT NEOSTRIATUM

      Journal of neuroscience research
    90. BYRNES EM; ABRAMS D; BRUNO JP
      COACTIVATION OF D1-LIKE AND D2-LIKE RECEPTORS IS UNNECESSARY FOR STIMULATED MOTOR BEHAVIOR IN RATS DEPLETED OF DOPAMINE DURING DEVELOPMENT

      Behavioural brain research
    91. WITKIN JM
      PHARMACOTHERAPY OF COCAINE ABUSE - PRECLINICAL DEVELOPMENT

      Neuroscience and biobehavioral reviews
    92. COLE DG; KOBIERSKI LA; KONRADI C; HYMAN SE
      6-HYDROXYDOPAMINE LESIONS OF RAT SUBSTANTIA-NIGRA UP-REGULATE DOPAMINE-INDUCED PHOSPHORYLATION OF THE CAMP-RESPONSE ELEMENT-BINDING PROTEININ STRIATAL NEURONS

      Proceedings of the National Academy of Sciences of the United Statesof America
    93. COUCEYRO P; POLLOCK KM; DREWS K; DOUGLASS J
      COCAINE DIFFERENTIALLY REGULATES ACTIVATOR PROTEIN-1 MESSENGER-RNA LEVELS AND DNA-BINDING COMPLEXES IN THE RAT STRIATUM AND CEREBELLUM

      Molecular pharmacology
    94. CRAWFORD CA; ROWLETT JK; MCDOUGALL SA; BARDO MT
      AGE-DEPENDENT DIFFERENCES IN THE RATE OF RECOVERY OF STRIATAL DOPAMINE D-1 AND D-2 RECEPTORS AFTER INACTIVATION WITH EEDQ

      European journal of pharmacology
    95. BURGER LY; MARTINIVERSON MT
      INCREASED OCCUPATION OF D-1 AND D-2 DOPAMINE-RECEPTORS ACCOMPANIES COCAINE-INDUCED BEHAVIORAL SENSITIZATION

      Brain research
    96. YUREK DM; HIPKENS SB
      INTRANIGRAL INJECTIONS OF SCH-23390 INHIBIT SKF-82958-INDUCED ROTATIONAL BEHAVIOR

      Brain research
    97. CICHON S; NOTHEN MM; RIETSCHEL M; KORNER J; PROPPING P
      SINGLE-STRAND CONFORMATION ANALYSIS (SSCA) OF THE DOPAMINE D1 RECEPTOR GENE (DRD1) REVEALS NO SIGNIFICANT MUTATION IN PATIENTS WITH SCHIZOPHRENIA AND MANIC-DEPRESSION

      Biological psychiatry
    98. BALDRIDGE WH; BALL AK
      A NEW-TYPE OF INTERPLEXIFORM CELL IN THE GOLDFISH RETINA IS PNMT-IMMUNOREACTIVE

      NeuroReport
    99. IZENWASSER S; KATZ JL
      DIFFERENTIAL EFFICACIES OF DOPAMINE D1 RECEPTOR AGONISTS FOR STIMULATING ADENYLYL-CYCLASE IN SQUIRREL-MONKEY AND RAT

      European journal of pharmacology. Molecular pharmacology section
    100. KOPIN IJ
      PARKINSONS-DISEASE - PAST, PRESENT, AND FUTURE

      Neuropsychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 22:59:34